Scientists from the University of Sheffield in the UK have identified new messenger molecules shuttled between cells which could help to protect the survival of neurones potentially leading to new treatments for Motor Neurone Disease (MND).
MND or Amyotrophic Lateral Sclerosis (ALS) is a neurological disorder in which the nerve cells -- neurones -- controlling the muscles that enable us to move, speak, breathe and swallow undergo degeneration and die.
The disorder affects 5,000 adults in the UK and there is currently no cure.
The pioneering research has discovered the role of a small molecule which can regulate large signalling cascades and significantly improve the survival of neurones something which will help pave the way to identify and develop new therapies for neuro-degenerative diseases.
Approximately 10 per cent of the MND cases are inherited. The remaining 90 per cent cases are caused by complex genetic and environmental interactions, which are currently not well understood.
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)